Listen "Addressing Disparities in Women's Healthcare - Sabrina Johnson, CEO Daré Bioscience"
Episode Synopsis
Despite being over half of the population women's health care lags behind other areas of drug development. The problem is caused by many facets, but is augmented by the fact that many of the conditions are not life threatening or are functions of aging. Sabrina Johnson, CEO of Daré Bioscience, discusses how the disparity exists, the pipeline of drugs that seek to mitigate female-specific conditions, and how smaller, leaner businesses can have significant impacts in this space.
More episodes of the podcast Talking Biotech with Dr. Kevin Folta
Drug Discovery in the Synapse - Derek Small
13/09/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.